Ignite Creation Date:
2025-12-25 @ 4:37 AM
Ignite Modification Date:
2025-12-26 @ 3:39 AM
Study NCT ID:
NCT05680818
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-31
First Post:
2022-12-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Sponsor:
Calcilytix Therapeutics, Inc., a BridgeBio company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-12
First Submit QC Date:
None
Study First Post Date:
2023-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-10-31
Last Update Post Date Type:
ESTIMATED